Addex Therapeutics Ltd Long-term Investment Intensity

Latest as of March 2026: 61.0%

Addex Therapeutics Ltd long-term investment intensity. Addex Therapeutics Ltd (ADXN) has a Long-term Investment Intensity of 61.0% as of March 2026. Long-term investments of CHF2.90 Million represent 61.0% of total assets of CHF4.76 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Addex Therapeutics Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

61.0%
LT Investments / Total Assets

Long-term Investments

CHF2.90 Million
CHF

Total Assets

CHF4.76 Million
CHF

Country

Switzerland
SW

Long-term Investment Intensity of Addex Therapeutics Ltd (2024–2025)

Long-term investment intensity of Addex Therapeutics Ltd from 2024 to 2025. This chart shows how Addex Therapeutics Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the intensity stands at 61.0%, reflecting long-term investments of CHF2.90 Million against total assets of CHF4.76 Million CHF.

Addex Therapeutics Ltd Long-term Investment Intensity by Year (2024–2025)

Addex Therapeutics Ltd long-term investment intensity by year from 2024 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Addex Therapeutics Ltd from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Addex Therapeutics Ltd (ADXN) total assets.

Year LT Investment Intensity LT Investments (CHF) Total Assets Change (pp)
2025 65.0% CHF4.13 Million CHF6.36 Million ▼ -1.4 pp
2024 66.4% CHF7.09 Million CHF10.67 Million —
pp = percentage points